About Aisa Pharma
Aisa Pharma is a Healthcare company based in Boston (United States) founded in 2017 by Andrew Sternlicht. It develops innovative therapeutics for treating autoimmune diseases. It operates on a B2B model. Its chief executive, as recorded, is Andrew Sternlicht. Its focus areas include Pharmaceuticals, Therapeutics and Autoimmune Diseases. Similar companies include Moderna, Forge Biologics and Annexon; 3 of its 3 listed similar companies have raised funding.
Company details
Aisa Pharma, established in 2017, excels in providing healthcare solutions, producing pharmaceutical products, therapeutics, and autoimmune diseases. Develops innovative therapeutics for treating autoimmune diseases. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Boston, United States
- Founders Andrew Sternlicht
- SectorsHealthcare
- Website aisapharma.com
People of Aisa Pharma
1 people are tracked at Aisa Pharma (1 in leadership).
| Name | Role | Group |
|---|---|---|
Andrew Sternlicht | Founder, CEO | Leadership |
Complete people profiles for Aisa Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Similar companies to Aisa Pharma
Aisa Pharma has 3 listed similar companies in our database, 3 of them funded. They include Moderna, Forge Biologics and Annexon.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| modernatx.com | 2010 | Cambridge, United States | $2.78B | 1,312 | mRNA-based therapeutics for diseases including cancer and infections are developed. | |
| forgebiologics.com | 2020 | Columbus, United States | $250M | 118 | Gene therapies for rare diseases are developed to treat patients. | |
| annexonbio.com | 2011 | San Francisco, United States | $256M | 80 | Developer of antibodies to treat complement-mediated neurodegenerative diseases |
Detailed similar companies of Aisa Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Aisa Pharma
The website of Aisa Pharma (aisapharma.com) receives about 1.6K visits a month.
- Monthly visits1.6K
▲ 2% vs previous month
Websites whose visitors overlap most with Aisa Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| elektrofi.com | 95% | 4.3K | #4,228,600 | View details | |
| octagontherapeutics.com | 92% | 2K | #8,651,290 | View details | |
| pieris.com | 27% | View details | |||
| praxismedicines.com | 25% | 35.6K | #1,244,570 | View details | |
| ensoma.com | 24% | 2.8K | #4,644,561 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 8 similar websites and full traffic analytics for Aisa Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Immunology & Cancer Therapeutics
3 companies that operate in the same segment as Aisa Pharma (Immunology & Cancer Therapeutics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | |||
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Aisa Pharma
Complete news archive for Aisa Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aisa Pharma
Aisa Pharma was founded in 2017.
Aisa Pharma is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Andrew Sternlicht is the CEO of Aisa Pharma, as recorded in our data. They have also founded this company.
Aisa Pharma, established in 2017, excels in providing healthcare solutions, producing pharmaceutical products, therapeutics, and autoimmune diseases. Develops innovative therapeutics for treating autoimmune diseases. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.
Aisa Pharma's top competitors include Moderna, Forge Biologics and Annexon.